These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 16105753)
1. Runx1/AML1 in normal and abnormal hematopoiesis. Yamagata T; Maki K; Mitani K Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753 [TBL] [Abstract][Full Text] [Related]
2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
3. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis. Lam K; Zhang DE Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794 [TBL] [Abstract][Full Text] [Related]
4. Core binding factor genes and human leukemia. Hart SM; Foroni L Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Heibert SW; Lutterbach B; Durst K; Wang L; Linggi B; Wu S; Wood L; Amann J; King D; Hou Y Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S31-4. PubMed ID: 11587363 [TBL] [Abstract][Full Text] [Related]
6. Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Perry C; Eldor A; Soreq H Leuk Res; 2002 Mar; 26(3):221-8. PubMed ID: 11792409 [TBL] [Abstract][Full Text] [Related]
7. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471 [TBL] [Abstract][Full Text] [Related]
8. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Osato M Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185 [TBL] [Abstract][Full Text] [Related]
9. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice. Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283 [TBL] [Abstract][Full Text] [Related]
10. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Asou N Crit Rev Oncol Hematol; 2003 Feb; 45(2):129-50. PubMed ID: 12604126 [TBL] [Abstract][Full Text] [Related]
11. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867 [TBL] [Abstract][Full Text] [Related]
12. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Ganly P; Walker LC; Morris CM Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191 [TBL] [Abstract][Full Text] [Related]
13. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells. Okumura AJ; Peterson LF; Lo MC; Zhang DE Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052 [TBL] [Abstract][Full Text] [Related]
14. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10398-403. PubMed ID: 11526243 [TBL] [Abstract][Full Text] [Related]
15. The 8;21 translocation in leukemogenesis. Peterson LF; Zhang DE Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181 [TBL] [Abstract][Full Text] [Related]
16. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488 [TBL] [Abstract][Full Text] [Related]
17. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis. Peterson LF; Lo MC; Okumura AJ; Zhang DE Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541 [TBL] [Abstract][Full Text] [Related]
18. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Tsuzuki S; Seto M; Greaves M; Enver T Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899 [TBL] [Abstract][Full Text] [Related]
19. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice. Hyde RK; Zhao L; Alemu L; Liu PP Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748 [TBL] [Abstract][Full Text] [Related]
20. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]